Published on
November 27, 2019
- 12:00 GMT
Verrica Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application for VP-102 for the Treatment of Molluscum ...
- PDUFA date assigned is July 13, 2020 - - VP-102 (cantharidin 0.7% Topical Solution) could potentially be the first FDA-approved treatment for molluscum contagiosum, a highly contagious viral skin infection affecting approximately 6 million people in the …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Media, Advertising & PR
...
